Stockreport

Acer Therapeutics Pauses ACER-801 Program After Trial Misses Topline Results [MarketWatch]

Acer Therapeutics Inc.  (ACER) 
Last acer therapeutics inc. earnings: 3/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: acertx.com/investor-relations
PDF severe vasomotor symptoms associated with menopause didn't achieve statistical significance even though it was safe and well-tolerated. The Newton, Mass.-based pharmac [Read more]